The study, which was simultaneously published in Circulation and presented as a Late-Breaking Clinical Trial at the American Heart Association Scientific Sessions, marked a significant step toward ...

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...

The device may help boost early detection of HFrEF for people living in low-resource settings where echo is scarce.

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, ...

Wave's pivotal trial, Dr. William Abraham is working on another heart failure trial as the new CMO at Cardiac Dimensions.

A new artificial intelligence (AI) screening model has demonstrated unprecedented accuracy in distinguishing cardiac amyloidosis (CA) from other heart conditions that mimic its appearance on ...

There never seems to be a dull moment for the Atlanta Braves. Even when the season is coming to a close, and they're days away from packing it up for the year, something popped up. This time, first ...

Heart failure with preserved ejection fraction (known as HFpEF), is the most common kind of heart failure, affecting millions globally. The heart still pumps, it just can't relax and fill ...

Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...

Department of Ultrasound, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China Background: Echocardiography is a cornerstone in the clinical diagnosis of ...